Sarcoma / 2017 / Article / Fig 2

Clinical Study

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors

Figure 2

Waterfall plots showing change in 2-dimensional tumor measurements according to WHO criteria after 4 cycles (2 cycles ifosfamide and doxorubicin, IA, and 2 cycles of ifosfamide and etoposide, IE, upper panels) and 2 cycles (IA, lower panels). On all four panels patients are arranged by best response measured after cycle 4. Patients removed from treatment after cycle 2. Target lesion stable, but progressive disease with new lesion.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.